Understanding the Molecular Basis for Homodimer Formation of the Pneumococcal Endolysin Cpl-1

Area of Science:

• Microbiology
• Biochemistry
• Structural Biology

Background:

• The increasing prevalence of multi-drug-resistant bacteria necessitates novel therapeutic strategies beyond traditional antibiotics.
• Endolysins, bacteriophage-derived enzymes, show promise as antibacterial agents due to their targeted action against bacterial peptidoglycan.
• Cpl-1 is an endolysin effective against Streptococcus pneumoniae, a significant human pathogen.

Purpose of the Study:

• To elucidate the molecular mechanisms governing the homodimerization of the endolysin Cpl-1.
• To investigate the role of specific residues in Cpl-1 dimer formation in the presence of choline.
• To identify conserved sequences involved in choline-dependent dimerization for potential therapeutic engineering.

Main Methods:

• Site-directed mutagenesis was employed to alter specific residues within the Cpl-1 structure.
• Analytical size exclusion chromatography and analytical ultracentrifugation were used to assess protein complex formation.
• Alanine scanning mutagenesis was performed on the C-terminal tail region to identify key mediating residues.

Main Results:

• The study disproved the involvement of N-terminal CWBD residues in Cpl-1 dimerization.
• The C-terminal tail region of Cpl-1 was conclusively identified as essential for homodimer formation.
• A consensus sequence (FxxEPDGLIT) critical for choline-dependent dimer formation was identified.

Conclusions:

• The C-terminal tail region, not the N-terminal CWBD, is responsible for Cpl-1 dimerization.
• The identified consensus sequence is prevalent in pneumococcal autolysins and endolysins, suggesting a conserved dimerization mechanism.
• These findings provide a mechanistic basis for engineering Cpl-1 and related endolysins for enhanced therapeutic applications against S. pneumoniae infections.